Multidisciplinary care for patients with breast cancer (Q33932014)

30 July 2017

1 reference

title

Multidisciplinary care for patients with breast cancer. (English)

1 reference

30 July 2017

Shuster TD

1

1 reference

30 July 2017

Girshovich L

series ordinal

2

1 reference

30 July 2017

Whitney TM

series ordinal

3

1 reference

30 July 2017

Hughes KS

series ordinal

4

1 reference

30 July 2017

language of work or name

1 reference

1 April 2000

1 reference

Surgical Clinics of North America

30 July 2017

published in

1 reference

30 July 2017

volume

80

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

505-533

1 reference

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Adequate locoregional treatment for early breast cancer may prevent secondary dissemination

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

An evaluation of bone scans as screening procedures for occult metastases in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Risk factors in breast-conservation therapy.

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Guidelines for Sentinel Node Biopsy and Lymphatic Mapping of Patients With Breast Cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

The Efficacy of Neoadjuvant Chemotherapy Compared to Postoperative Therapy in the Treatment of Locally Advanced Breast Cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of f

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4). Discriminants for 15-year survival. National Surgical Adjuvant Breast and Bowel Project Investigators

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

The influence of angiogenesis research on management of patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Cardiac doses in post-operative breast irradiation

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast.

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Oncological aspects of immediate breast reconstruction following mastectomy for malignancy

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Scientific panel clears breast implants

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

The sentinel node in breast cancer--a multicenter validation study

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Mammary recurrences in women younger than forty

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

The prognostic significance of late local recurrence after breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Prognostic factors and treatment decisions in axillary-node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Estrogen receptor versus nuclear grade as prognostic factors in axillary node negative breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Management, morbidity, and oncologic aspects in 100 consecutive patients with immediate breast reconstruction

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Bone metastases from breast cancer at the time or radical mastectomy as detected by bone scan. Eight-year follow-up

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Immediate breast reconstruction in patients with locally advanced disease

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Histological grading of breast cancer. Interobserver, reproducibility and prognostic significance

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Changing trends in postmastectomy breast reconstruction: a 13-year experience.

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Histopathologic Validation of the Sentinel Lymph Node Hypothesis for Breast Carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial.

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

TRAM flap breast reconstruction after radiation treatment

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Standards for diagnosis and management of invasive breast carcinoma. American College of Radiology. American College of Surgeons. College of American Pathologists. Society of Surgical Oncology

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70199-7

7 January 2021

10.1016/S0039-6109(05)70199-7

Identifiers

DOI

1 reference

30 July 2017

1 reference